• Logo
  • SBMUJournals

Small Cell Carcinoma of Bladder; Still A Diagnostic and Therapeutic Challenge: Seven Years of Experience and Follow-up in A Referral Center

Reza Kaffash Nayeri, Mohammad Sadri, Hossein Shahrokh, Maryam Abolhasani, Farhood khaleghimehr, Ehsan Zolfi, Naser Yousefzadeh Kandevani, Amir Hossein Kashi
82

Views


Abstract

Purpose: To report clinical, histopathological, and treatment features of small cell carcinoma of (SmccB) bladder during 7 years in a referral center.

Methods: The clinical, histopathological features, treatment modalities, and outcome of all patients with bladder SmccB treated between 2009 and 2016 who were managed in Hasheminejad Kidney Center (HKC) were retrospectively collected.

Results: Thirteen patients were diagnosed and managed with SmccB. The average age of patients was 64.92 years. For each patient, 8 markers were used for IHC staining on average. Neuroendocrine markers such as CD 56, Neuron Specific Enolase, Synaptophysin, and Chromogranin were found in a significant percentage of patients (69%, 38%, 54%, and 31% respectively). Patients were managed with TURBT alone (N=3), chemotherapy after TURBT (N=4), chemotherapy plus radical surgery (N=4) and radical surgery alone (N=2). The best clinical result was seen in chemotherapy received patients with or without radical surgery. The mean(SE) of survival rate in patients who received only chemotherapy alone was 42.4 (10.0) months, while in those who were managed with chemotherapy plus radical surgery it was 47.7 (10.1) months.

Discussion: In our center immunohistochemistry was needed for definitive diagnosis in 17/19 samples. Misdiagnosis happened in two samples without IHC request. We think that use of immunohistochemistry should be mandatory for diagnosis of SmccB to exclude misdiagnosis. Chemotherapy is the most important part of treatment and the addition of radical surgery can slightly improve patients’ survival.


References

References

Shatagopam K, Kaimakliotis HZ, Cheng L, Koch MO. Genitourinary small cell malignancies: prostate and bladder. Future oncology (London, England). 2015;11(3):479-88.

Pant-Purohit M, Lopez-Beltran A, Montironi R, MacLennan GT, Cheng L. Small cell carcinoma of the urinary bladder. Histology and histopathology. 2010;25(2):217-21,

Wong YN, Jack RH, Mak V, Henrik M, Davies EA. The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. BMC cancer. 2009; 9:209.

Blomjous CE, Vos W, De Voogt HJ, Van der Valk P, Meijer CJ. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer. 1989;64(6):1347-57.

Holmang S, Borghede G, Johanson S, et al. Primary small cell carcinoma of the bladder: A report of 25 cases. J Urol 1995; 153:1820-2.

Moretto P, Wood L, Emmenegger U, Blais N, Mukherjee SD, Winquist E, et al. Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2013;7(1-2): E44-56.

Kouba EJ, Cheng L. Understanding the Genetic Landscape of Small Cell Carcinoma of the Urinary Bladder and Implications for Diagnosis, Prognosis, and Treatment: A Review. JAMA oncology. 2017;3(11):1570-8.

Berniker AV, Abdulrahman AA, Teytelboym OM, Galindo LM, Mackey JE. Extrapulmonary small cell carcinoma: imaging features with radiologic-pathologic correlation. Radiographics: a review publication of the Radiological Society of North America, Inc. 2015;35(1):152-63.

Pasquier D, Barney B, Sundar S, et al. Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients. International journal of radiation oncology, biology, physics. 2015;92(4):904-10.

Cramer SF, Aikawa M, Cebelin M. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. Cancer. 1981;47(4):724-30.

Linder BJ, Boorjian SA, Cheville JC, Sukov WR, Thapa P, Tarrell RF, et al. The impact of histological reclassification during pathology re-review--evidence of a Will Rogers effect in bladder cancer? The Journal of urology. 2013;190(5):1692-6.

Amin MB. Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2009;22 Suppl 2:S96-s118.

Bajetta E, Catena L, Procopio G, et al. Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Annals of oncology: official journal of the European Society for Medical Oncology. 2005;16(8):1374-80.

Thota S, Kistangari G, Daw H, Spiro T. A clinical review of small-cell carcinoma of the urinary bladder. Clinical genitourinary cancer. 2013;11(2):73-7.

Abrahams NA, Moran C, Reyes AO, Siefker-Radtke A, Ayala AG. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases. Histopathology. 2005;46(1):57-63.

Epstein J, Reuter V, Amin M. Biopsy interpretation of bladder, 2010, 2nd edition, Lippincott, Williams & Wilkins, P 147-9.

Ordonez NG, Khorsand J, Ayala AG, Sneige N. Oat cell carcinoma of the urinary tract. An immunohistochemical and electron microscopic study. Cancer. 1986;58(11):2519-30.

Trias I, Algaba F, Condom E, et al. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. European urology. 2001;39(1):85-90.

Zhao X, Flynn EA. Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy. Archives of pathology & laboratory medicine. 2012;136(11):1451-9.

Jones TD, Kernek KM, Yang XJ, et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Human pathology. 2005;36(7):718-23.

Wang X, MacLennan GT, Lopez-Beltran A, Cheng L. Small cell carcinoma of the urinary bladder--histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis. Applied immunohistochemistry & molecular morphology: AIMM. 2007;15(1):8-18.

Lynch SP, Shen Y, Kamat A, et al. Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. European urology. 2013;64(2):307-13.

Bhatt VR, Loberiza FR, Jr., Tandra P, Krishnamurthy J, Shrestha R, Wang J. Risk factors, therapy and survival outcomes of small cell and large cell neuroendocrine carcinoma of urinary bladder. Rare tumors. 2014;6(1):5043.

Pasquier D, Barney B, Sundar S, et al. Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients. International journal of radiation oncology, biology, physics. 2015;92(4):904-10.

Bryant CM, Dang LH, Stechmiller BK, Gilbert SM, Morris CG, Zlotecki RA. Treatment of Small Cell Carcinoma of the Bladder with Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor. American journal of clinical oncology. 2016;39(1):69-75.

Schreiber D, Rineer J, Weiss J, et al. Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database. American journal of clinical oncology. 2013;36(2):126-31.

Boyer AC, Jafri SZ, Jafri SM, Amin MB. Neuroendocrine carcinoma of the urinary bladder: a retrospective study of CT findings. Abdominal imaging. 2013;38(4):870-6.

Mackey JR, Au HJ, Hugh J, Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. The Journal of urology. 1998;159(5):1624-9.

. Buza N, Cohen PJ, Pei Hui, Parkash V. Inverse p16 and p63 expression in small cell carcinoma and high-grade urothelial cell carcinoma of the urinary bladder. Int J Surg Pathol. 2010;18(2):94–102




DOI: http://dx.doi.org/10.22037/uj.v0i0.5289

Refbacks

  • There are currently no refbacks.